Why healthy subjects volunteer for phase I studies and how they perceive their participation?

European Journal of Clinical Pharmacology

Volumn 63, Issue 11, 2007, Pages 1085-1094

  Almeida, Luis ^a,b   Azevedo, Benedita ^a   Nunes, Teresa ^a   Vaz Da Silva, Manuel ^a,b,c   Soares Da Silva, Patrício ^a,b  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^b University of Porto   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Clinical pharmacology; Healthy subjects; Phase I studies; Recruitment; Volunteering

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; ATTITUDE; CONSULTATION; DECISION MAKING; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; LOWEST INCOME GROUP; MALE; MOTIVATION; NORMAL HUMAN; OCCUPATION; PATIENT PARTICIPATION; PERSONALITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; REWARD; STATISTICAL ANALYSIS; VOLUNTEER;

ADOLESCENT; ADULT; CLINICAL TRIALS, PHASE I AS TOPIC; DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; MOTIVATION; PATIENT SELECTION; PERSONALITY; QUESTIONNAIRES; REWARD; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 35248865300     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0368-3     Document Type: Article

References (29)

1. Tishler CL, Bartholomae S (2002) The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol 42:365-375
2. Bigorra J, Baños JE (1990) Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials. Eur J Clin Pharmacol 38:443-446
3. Esecover H, Malitz S, Wilkens B (1961) Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies. Am J Psychiatry 117:910-915
4. Hassar M, Pocelinko R, Weintraub M, Nelson D, Thomas G, Lasagna L (1977) Free-living volunteer's motivations and attitudes toward pharmacologic studies in man. Clin Pharmacol Ther 21:515-519
5. Martin DC, Arnold JD, Zimmerman TF, Richart RH (1968) Human subjects in clinical research: a report of three studies. N Engl J Med 279:1426-1431
6. Novak E, Seckman CE, Stewart RD (1977) Motivations for volunteering as research subjects. J Clin Pharmacol 365-371
7. Van Gelderen CEM, Savelkoul TJF, Van Dokkum W, Meulenbelt J (1993) Motives and perception of healthy volunteers who participate in experiments. Eur J Clin Pharmacol 45:15-21
8. Vrlovac R, Francetic I, Rotim K (1990) Drug trials on healthy volunteers in Yugoslavia. Int J Clin Pharmacol Ther Toxicol 28:375-379
9. Costa PT, McCrae RR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI). Professional manual. Psychological Assessment Resources, Odessa, FL
10. Digman JM (1990) Emergence of the five factor. Annu Rev Psychol 41:417-440
11. Goldberg LR (1990) An alternative "Description of Personality": the big-five factor structure. J Pers Soc Psychol 59:1216-1229
12. Pedroso-de-Lima M, Simões A (2000) NEO PI-R: Inventário de Personalidade NEO Revisto. Manual profissional. CEGOC-TEA, Ltd, Lisbon
13. Rocha D (2000) NEO PI-R: CEGOC system, software para cotação informatizada do teste NEO-PI-R. CEGOC-TEA, Lisbon
14. Anderson JA, Weijer C (2001) The research subject as entrepeneur. Am J Bioethics 1:67-69
15. Ayd FJ, Calabresi P (1972) Motivations and rewards for volunteering to be an experimental subject. Clin Pharmacol Ther 13:771-781
16. Dickert N, Grady C (1999) What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 341:198-203
17. Erb K, Staks T, Su C-A (1994) Trends in the remuneration of volunteers. Appl Clin Trials 3:54-58
18. Gribbin K, Schaie KW (1976) Monetary incentive, age, and cognition. Exp Aging Res 2:461-468
19. Hyun I (2006) Fair payment or undue inducement? Nature 442:629-630
20. McGee C (1997) A piece of my mind: subject to payment? JAMA 278:199-200
21. Russel ML, Moralejo DG, Burgess ED (2000) Paying research subjects: participant's perspectives. J Med Ethics 26:126-130
22. Tishler CL, Bartholomae S (2003) Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials? Perspect Biol Med 46:508-520
23. Vere DW (1991) Payments to healthy volunteers: ethical problems. Br J Clin Pharmacol 32:141-142
24. Viens AM (2001) Socio-economic status and inducement to participate. Am J Bioethics 1:69
25. Weijer C (1999) What's the price of a research subject? N Engl J Med 341:206
26. Zink S (2001) Maybe we should pay them more. Am J Bioethics 1:88-89
27. Almeida L, Azevedo B, Nunes T, Vaz-da-Silva M, Albino-Teixeira A, Falcao A, Coelho R, Soares-da-Silva P (2006) Healthy subjects' motivations to volunteer for participation in human pharmacology studies (Abstr 1071). J Clin Pharmacol 46:1077
28. Newton L (1982) Inducement, due and otherwise. IRB 4:4-6
29. Rabin C, Tabak N (2006) Healthy participants in phase I clinical trials: the quality of their decision to take part. J Clin Nurs 15:971-979